Pressure-Induced Changes in Astrocyte GFAP, Actin, and Nuclear Morphology in Mouse Optic Nerve.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 09 2020
01 09 2020
Historique:
entrez:
10
9
2020
pubmed:
11
9
2020
medline:
1
4
2021
Statut:
ppublish
Résumé
To conduct quantitative analysis of astrocytic glial fibrillary acidic protein (GFAP), actin and nuclei distribution in mouse optic nerve (ON) and investigate changes in the measured features after 3 days of ocular hypertension (OHT). Serial cross-sections of 3-day microbead-induced OHT and control ONs were fluorescently labelled and imaged using confocal microscope. Eighteen structural features were measured from the acquired images, including GFAP coverage, actin area fraction, process thickness, and aspect ratio of cell nucleus. The measured features were analyzed for variations with axial locations along ON and radial zones transverse to ON, as well as for the correlations with degree of intraocular pressure (IOP) change. The most significant changes in structural features after 3-day OHT occurred in the unmyelinated ON region (R1), and the changes were greater with greater IOP elevation. Although the GFAP, actin, axonal, and ON areas all increased in 3-day OHT ONs in R1 (P ≤ 0.004 for all), the area fraction of GFAP actually decreased (P = 0.02), the actin area fraction was stable and individual axon compartments were unchanged in size. Within R1, the number of nuclear clusters increased (P < 0.001), but the mean size of nuclear clusters was smaller (P = 0.02) and the clusters became rounder (P < 0.001). In all cross-sections of control ONs, astrocytic processes were thickest in the rim zone compared with the central and peripheral zones (P ≤ 0.002 for both), whereas the overall process width in R1 decreased after 3 days of OHT (P < 0.001). The changes in structure elucidated IOP-generated alterations that underlie astrocyte mechanotranslational responses relevant to glaucoma.
Identifiants
pubmed: 32910133
pii: 2770777
doi: 10.1167/iovs.61.11.14
pmc: PMC7488631
doi:
Substances chimiques
Actins
0
Glial Fibrillary Acidic Protein
0
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
14Subventions
Organisme : NEI NIH HHS
ID : P30 EY001765
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Glia. 2013 Aug;61(8):1218-35
pubmed: 23650091
Invest Ophthalmol. 1974 Jun;13(6):455-7
pubmed: 4208801
Invest Ophthalmol. 1974 Oct;13(10):771-83
pubmed: 4137635
Arch Ophthalmol. 1990 Jul;108(7):1020-4
pubmed: 2369339
Neurochem Res. 2015 Feb;40(2):372-9
pubmed: 24952067
J Comp Neurol. 2009 Sep 1;516(1):1-19
pubmed: 19562764
Nature. 1994 Jun 30;369(6483):744-7
pubmed: 7911978
J Glaucoma. 1997 Oct;6(5):303-13
pubmed: 9327349
J Neurosci Res. 2001 Oct 1;66(1):59-73
pubmed: 11599002
Nat Commun. 2017 Mar 20;8:14787
pubmed: 28317912
J Cell Sci. 1993 Feb;104 ( Pt 2):353-63
pubmed: 8505365
J Histochem Cytochem. 1990 Sep;38(9):1383-8
pubmed: 2201738
J Neurosci. 2010 Oct 20;30(42):14008-19
pubmed: 20962222
Exp Eye Res. 2020 Jul;196:108035
pubmed: 32353427
Dev Biol. 1997 Jul 1;187(1):36-42
pubmed: 9224672
Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2765-2773
pubmed: 28549091
Rep Prog Phys. 2017 Mar;80(3):036601
pubmed: 28129208
PLoS Comput Biol. 2019 Sep 11;15(9):e1007289
pubmed: 31509522
J Cell Sci. 2015 Sep 15;128(18):3375-85
pubmed: 26243474
PLoS One. 2020 Aug 21;15(8):e0238104
pubmed: 32822415
Acta Biomater. 2017 Aug;58:278-290
pubmed: 28528864
Invest Ophthalmol Vis Sci. 1980 Feb;19(2):137-52
pubmed: 6153173
Arch Ophthalmol. 1981 Apr;99(4):635-49
pubmed: 6164357
Exp Eye Res. 2018 Jul;172:78-85
pubmed: 29625080
Front Cell Neurosci. 2018 Mar 16;12:69
pubmed: 29615869
Arch Ophthalmol. 2003 Jan;121(1):48-56
pubmed: 12523884
Exp Eye Res. 2017 Jul;160:106-115
pubmed: 28414059
Biochem Cell Biol. 1993 Jan-Feb;71(1-2):27-35
pubmed: 8329174
J Neurosci. 2007 Jun 20;27(25):6607-19
pubmed: 17581948
Traffic. 2007 Jan;8(1):12-20
pubmed: 17229312
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):924-932
pubmed: 28170536
Exp Eye Res. 2012 Jun;99:27-35
pubmed: 22554836
Exp Eye Res. 2010 Sep;91(3):415-24
pubmed: 20599961
Prog Retin Eye Res. 2000 May;19(3):297-321
pubmed: 10749379
Exp Eye Res. 1987 Apr;44(4):537-51
pubmed: 2439361
Invest Ophthalmol Vis Sci. 2013 Feb 01;54(2):909-17
pubmed: 23322566
Science. 2009 Nov 27;326(5957):1208-12
pubmed: 19965462
PLoS One. 2013 Jun 27;8(6):e67094
pubmed: 23826199
J Biochem. 2017 Mar 1;161(3):245-254
pubmed: 28082721
J Biomech Eng. 2018 Aug 1;140(8):
pubmed: 30003249
Glia. 1992;5(2):81-94
pubmed: 1349588
Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):721-733
pubmed: 28146237
J Neurosci. 2008 Mar 12;28(11):2735-44
pubmed: 18337403
Annu Rev Cell Dev Biol. 2018 Oct 6;34:1-28
pubmed: 30059630
Invest Ophthalmol Vis Sci. 2003 Oct;44(10):4321-30
pubmed: 14507876
Ophthalmology. 1979 Oct;86(10):1803-30
pubmed: 553256
Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2406-2422
pubmed: 31157833
J Cell Biol. 2007 Dec 31;179(7):1523-37
pubmed: 18158332
PLoS One. 2016 Nov 28;11(11):e0167364
pubmed: 27893827
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):921-932
pubmed: 30835784
Acta Neuropathol. 2011 Jun;121(6):737-51
pubmed: 21311901
J Cell Biol. 2017 Jun 5;216(6):1689-1703
pubmed: 28432079
FASEB J. 2011 Feb;25(2):624-31
pubmed: 20974670
Mol Vis. 2015 Jul 14;21:749-66
pubmed: 26236150
Invest Ophthalmol Vis Sci. 1977 May;16(5):426-41
pubmed: 67096
Biomaterials. 2010 Jul;31(20):5345-54
pubmed: 20398930
Anat Embryol (Berl). 1995 Jun;191(6):491-502
pubmed: 7677257
Neuroscience. 2004;129(4):877-96
pubmed: 15561405
J Cell Physiol. 1995 Apr;163(1):179-93
pubmed: 7534769
Invest Ophthalmol Vis Sci. 2000 Feb;41(2):431-42
pubmed: 10670473
Invest Ophthalmol Vis Sci. 2015 Mar 03;56(3):2031-42
pubmed: 25736791
Invest Ophthalmol Vis Sci. 2007 Jul;48(7):3161-77
pubmed: 17591886